Correlation Between Mediwound and Rigel Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mediwound and Rigel Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mediwound and Rigel Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mediwound and Rigel Pharmaceuticals, you can compare the effects of market volatilities on Mediwound and Rigel Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mediwound with a short position of Rigel Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mediwound and Rigel Pharmaceuticals.

Diversification Opportunities for Mediwound and Rigel Pharmaceuticals

-0.43
  Correlation Coefficient

Very good diversification

The 3 months correlation between Mediwound and Rigel is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Mediwound and Rigel Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rigel Pharmaceuticals and Mediwound is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mediwound are associated (or correlated) with Rigel Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rigel Pharmaceuticals has no effect on the direction of Mediwound i.e., Mediwound and Rigel Pharmaceuticals go up and down completely randomly.

Pair Corralation between Mediwound and Rigel Pharmaceuticals

Given the investment horizon of 90 days Mediwound is expected to under-perform the Rigel Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Mediwound is 3.55 times less risky than Rigel Pharmaceuticals. The stock trades about -0.05 of its potential returns per unit of risk. The Rigel Pharmaceuticals is currently generating about 0.37 of returns per unit of risk over similar time horizon. If you would invest  1,363  in Rigel Pharmaceuticals on September 1, 2024 and sell it today you would earn a total of  1,398  from holding Rigel Pharmaceuticals or generate 102.57% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Mediwound  vs.  Rigel Pharmaceuticals

 Performance 
       Timeline  
Mediwound 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Mediwound are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound basic indicators, Mediwound is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
Rigel Pharmaceuticals 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Rigel Pharmaceuticals are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite quite unfluctuating technical and fundamental indicators, Rigel Pharmaceuticals disclosed solid returns over the last few months and may actually be approaching a breakup point.

Mediwound and Rigel Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mediwound and Rigel Pharmaceuticals

The main advantage of trading using opposite Mediwound and Rigel Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mediwound position performs unexpectedly, Rigel Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rigel Pharmaceuticals will offset losses from the drop in Rigel Pharmaceuticals' long position.
The idea behind Mediwound and Rigel Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Insider Screener
Find insiders across different sectors to evaluate their impact on performance